Pulmonx (LUNG) Non-Current Assets (2019 - 2025)
Pulmonx's (LUNG) quarterly Non-Current Assets came in at $27.6 million in Q4 2025, up 3.78% year-on-year from $26.6 million in Q4 2024, and up 2.07% on a QoQ basis from $27.0 million in Q3 2025.
Pulmonx (LUNG) Non-Current Assets (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Non-Current Assets data on file, last reported at $27.6 million in Q4 2025.
- On a quarterly basis, Non-Current Assets rose 3.78% year-over-year to $27.6 million in Q4 2025; TTM through Dec 2025 was $108.6 million, a 12.92% increase from a year earlier, with the FY2025 full-year figure at $27.6 million, up 3.78% from the prior year.
- Non-Current Assets for Q4 2025 stood at $27.6 million, up from $27.0 million in the prior quarter.
- Over the last five years, Non-Current Assets for LUNG reached as high as $37.7 million in Q3 2023 and fell as low as $15.9 million in Q2 2021.
- Historically, Non-Current Assets has averaged $24.1 million across 5 years, with a median of $26.5 million in 2024.
- Across the five-year window, Non-Current Assets jumped 98.05% in 2021 and retreated 29.69% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $27.2 million in 2021, then retreated by 9.01% to $24.7 million in 2022, then climbed by 10.66% to $27.4 million in 2023, then decreased by 2.77% to $26.6 million in 2024, then advanced by 3.78% to $27.6 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $27.6 million in Q4 2025, $27.0 million in Q3 2025, and $27.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | 27.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.61 Mn |
| Sep 30, 2025 | 27.05 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | 26.80 Mn |
| Dec 31, 2024 | 26.60 Mn |
| Sep 30, 2024 | 26.47 Mn |
| Jun 30, 2024 | 26.47 Mn |
| Mar 31, 2024 | 16.65 Mn |
| Dec 31, 2023 | 27.36 Mn |
| Sep 30, 2023 | 37.65 Mn |
| Jun 30, 2023 | 28.69 Mn |
| Mar 31, 2023 | 19.97 Mn |
| Dec 31, 2022 | 24.72 Mn |
| Sep 30, 2022 | 19.09 Mn |
| Jun 30, 2022 | 19.95 Mn |
| Mar 31, 2022 | 22.12 Mn |
| Dec 31, 2021 | 27.17 Mn |
| Sep 30, 2021 | 19.17 Mn |
| Jun 30, 2021 | 15.86 Mn |
| Mar 31, 2021 | 15.93 Mn |